Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Nadasdy

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Dermatologic Therapy|March 22, 2021
Chitin-lipid interactions and the potential relationship between Demodex and SARS-CoV-2Alin Laurentiu Tatu, Thomas Nadasdy, Lawrence Chukwudi Nwabudike
Dermatologic Therapy|August 15, 2020
Familial clustering of COVID-19 skin manifestationsAlin Laurentiu Tatu, Thomas Nadasdy, Florin Ciprian Bujoreanu
International Journal of General Medicine|September 19, 2022
New Antifibroblastic Medication in Dermatology: Could Nintedanib Treat Scarring?Patricia Liana Cristodor, Alexandru Nechifor, Silvia Fotea, et al.
Clinical, Cosmetic and Investigational Dermatology|May 7, 2021
A Working Hypothesis on Vesicular Lesions Related to COVID-19 Infection, Koebner Phenomena Type V, and a Short Review of Related DataAlin Laurentiu Tatu, Liliana Baroiu, Silvia Fotea, et al.
Experimental and Therapeutic Medicine|October 18, 2021
Nevi, biologics for psoriasis and the risk for skin cancer: A real concern? (Case presentation and short review)Florin Ciprian Bujoreanu, Laura Bezman, Diana Sabina Radaschin, et al.
Journal of Inflammation Research|September 16, 2022
Interrelationship and Sequencing of Interleukins4, 13, 31, and 33 - An Integrated Systematic Review: Dermatological and Multidisciplinary PerspectivesAlin Laurentiu Tatu, Thomas Nadasdy, Anca Arbune, et al.
Journal of Medical Virology|January 31, 2022
The global case fatality rate of coronavirus disease 2019 by continents and national income: A meta-analysisRamy Abou Ghayda, Keum Hwa Lee, Young Joo Han, et al.
Journal of Medical Virology|November 29, 2022
Nonpharmaceutical interventions reduce the incidence and mortality of COVID-19: A study based on the survey from the International COVID-19 Research Network (ICRN)Seung Hyun Park, Sung Hwi Hong, Kwanghyun Kim, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Dermatologic Therapy|March 22, 2021
Chitin-lipid interactions and the potential relationship between Demodex and SARS-CoV-2Alin Laurentiu Tatu, Thomas Nadasdy, Lawrence Chukwudi Nwabudike
Dermatologic Therapy|August 15, 2020
Familial clustering of COVID-19 skin manifestationsAlin Laurentiu Tatu, Thomas Nadasdy, Florin Ciprian Bujoreanu
International Journal of General Medicine|September 19, 2022
New Antifibroblastic Medication in Dermatology: Could Nintedanib Treat Scarring?Patricia Liana Cristodor, Alexandru Nechifor, Silvia Fotea, et al.
Clinical, Cosmetic and Investigational Dermatology|May 7, 2021
A Working Hypothesis on Vesicular Lesions Related to COVID-19 Infection, Koebner Phenomena Type V, and a Short Review of Related DataAlin Laurentiu Tatu, Liliana Baroiu, Silvia Fotea, et al.
Experimental and Therapeutic Medicine|October 18, 2021
Nevi, biologics for psoriasis and the risk for skin cancer: A real concern? (Case presentation and short review)Florin Ciprian Bujoreanu, Laura Bezman, Diana Sabina Radaschin, et al.
Journal of Inflammation Research|September 16, 2022
Interrelationship and Sequencing of Interleukins4, 13, 31, and 33 - An Integrated Systematic Review: Dermatological and Multidisciplinary PerspectivesAlin Laurentiu Tatu, Thomas Nadasdy, Anca Arbune, et al.
Journal of Medical Virology|January 31, 2022
The global case fatality rate of coronavirus disease 2019 by continents and national income: A meta-analysisRamy Abou Ghayda, Keum Hwa Lee, Young Joo Han, et al.
Journal of Medical Virology|November 29, 2022
Nonpharmaceutical interventions reduce the incidence and mortality of COVID-19: A study based on the survey from the International COVID-19 Research Network (ICRN)Seung Hyun Park, Sung Hwi Hong, Kwanghyun Kim, et al.
Pageof 1